{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:14:29Z","timestamp":1792062869809,"version":"4.4.0"},"reference-count":154,"publisher":"European Respiratory Society (ERS)","issue":"142","content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2016,10,12]]},"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:p>Malignant pleural mesothelioma is an aggressive malignancy of the pleural surface, predominantly caused by prior asbestos exposure. There is a global epidemic of malignant pleural mesothelioma underway, and incidence rates are predicted to peak in the next few years.<\/jats:p>\n                  <jats:p>This article summarises the epidemiology and pathogenesis of malignant pleural mesothelioma, before describing some key factors in the patient experience and outlining common symptoms. Diagnostic approaches are reviewed, including imaging techniques and the role of various biomarkers. Treatment options are summarised, including the importance of palliative care and methods of controlling pleural effusions. The evidence for chemotherapy, radiotherapy and surgery is reviewed, both in the palliative setting and in the context of trimodality treatment. An algorithm for managing malignant pleural effusion in malignant pleural mesothelioma patients is presented. Finally new treatment developments and novel therapeutic approaches are summarised.<\/jats:p>","DOI":"10.1183\/16000617.0063-2016","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T20:26:52Z","timestamp":1480537612000},"page":"472-486","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":268,"title":["Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment"],"prefix":"10.1183","volume":"25","author":[{"given":"Anna C.","family":"Bibby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina","family":"Tsim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Kanellakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis C.","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin G.","family":"Blyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick A.","family":"Maskell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Psallidas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2016,11,30]]},"reference":[{"key":"2024102403240632000_25.142.472.1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2007.087619"},{"key":"2024102403240632000_25.142.472.2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00063109"},{"key":"2024102403240632000_25.142.472.3","doi-asserted-by":"publisher","DOI":"10.1136\/thx.52.6.507"},{"key":"2024102403240632000_25.142.472.4","doi-asserted-by":"publisher","DOI":"10.1136\/oem.54.6.403"},{"key":"2024102403240632000_25.142.472.5","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgt166"},{"key":"2024102403240632000_25.142.472.6","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.1002845"},{"key":"2024102403240632000_25.142.472.7","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.lungcan.2015.03.005","article-title":"Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales","volume":"88","author":"Beckett","year":"2015","journal-title":"Lung Cancer"},{"key":"2024102403240632000_25.142.472.8","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2068"},{"key":"2024102403240632000_25.142.472.9","doi-asserted-by":"publisher","DOI":"10.2307\/3580117"},{"key":"2024102403240632000_25.142.472.10","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-R\u00edos F , Illei PB , Rusch V , et al. Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. Lancet 364: 1157\u20131166.","DOI":"10.1016\/S0140-6736(04)17102-X"},{"key":"2024102403240632000_25.142.472.11","first-page":"1781","article-title":"Simian virus 40-like DNA sequences in human pleural mesothelioma","volume":"9","author":"Carbone","year":"1994","journal-title":"Oncogene"},{"key":"2024102403240632000_25.142.472.12","first-page":"1524","article-title":"SV40 induces mesotheliomas in hamsters","volume":"142","author":"Cicala","year":"1993","journal-title":"Am J Pathol"},{"key":"2024102403240632000_25.142.472.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra050152"},{"key":"2024102403240632000_25.142.472.14","first-page":"2108","article-title":"Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas","volume":"9","author":"Illei","year":"2003","journal-title":"Clin Cancer Res"},{"key":"2024102403240632000_25.142.472.15","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-1008"},{"key":"2024102403240632000_25.142.472.16","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201100176"},{"key":"2024102403240632000_25.142.472.17","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/pon.3162","article-title":"'It's all bad news\u2019: the first 3\u2005months following a diagnosis of malignant pleural mesothelioma","volume":"22","author":"Arber","year":"2013","journal-title":"Psychooncology"},{"key":"2024102403240632000_25.142.472.18","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.hoc.2005.09.003","article-title":"Mesothelioma from the patient's perspective","volume":"19","author":"Clayson","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"key":"2024102403240632000_25.142.472.19","first-page":"1183","article-title":"A very public death: dying of mesothelioma and asbestos-related lung cancer (M\/ARLC) in the Latrobe Valley, Victoria, Australia","volume":"9","author":"Lee","year":"2009","journal-title":"Rural Remote Health"},{"key":"2024102403240632000_25.142.472.20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1017\/S1478951505050078","article-title":"Challenging the representations of cancer pain: experiences of a multidisciplinary pain management group in a palliative care unit","volume":"3","author":"Chapman","year":"2005","journal-title":"Palliat Support Care"},{"key":"2024102403240632000_25.142.472.21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ajim.4700040306","article-title":"Exposure to asbestos: psychological responses of mesothelioma patients","volume":"4","author":"Lebovits","year":"1983","journal-title":"Am J Ind Med"},{"key":"2024102403240632000_25.142.472.22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1179\/096992603322731143","article-title":"Suffering in mesothelioma: concepts and contexts","volume":"11","author":"Clayson","year":"2003","journal-title":"Prog Palliat Care"},{"key":"2024102403240632000_25.142.472.23","unstructured":"Hawley R , Monk A , Wiltshire J . The mesothelioma journey: developing strategies to meet the needs of people with mesothelioma, their family carers and health professionals involved in their care. Nursing Research Centre for Adaptation in Health and Illness, Sydney, 2004."},{"key":"2024102403240632000_25.142.472.24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.12968\/ijpn.2008.14.2.28597","article-title":"The lived experience of patients with pleural mesothelioma","volume":"14","author":"Hughes","year":"2008","journal-title":"Int J Palliat Nurs"},{"key":"2024102403240632000_25.142.472.25","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldp047"},{"key":"2024102403240632000_25.142.472.26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.09.147"},{"key":"2024102403240632000_25.142.472.27","first-page":"E254","article-title":"Guidelines for the diagnosis and treatment of malignant pleural mesothelioma","volume":"5","author":"van Zandwijk","year":"2013","journal-title":"J Thorac Dis"},{"key":"2024102403240632000_25.142.472.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60727-8"},{"key":"2024102403240632000_25.142.472.29","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdj073"},{"key":"2024102403240632000_25.142.472.30","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.136994"},{"key":"2024102403240632000_25.142.472.31","unstructured":"Clayson H . The experience of mesothelioma in Northern England. PhD thesis. University of Sheffield, Sheffield, UK. 2007."},{"key":"2024102403240632000_25.142.472.32","doi-asserted-by":"publisher","DOI":"10.1016\/0007-0971(83)90068-2"},{"key":"2024102403240632000_25.142.472.33","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.52.2.72"},{"key":"2024102403240632000_25.142.472.34","doi-asserted-by":"publisher","DOI":"10.1378\/chest.113.3.723"},{"key":"2024102403240632000_25.142.472.35","doi-asserted-by":"publisher","DOI":"10.1378\/chest.111.1.106"},{"key":"2024102403240632000_25.142.472.36","unstructured":"Lin K , Croswell JM , Koenig H , et al. Prostate-specific antigen-based screening for prostate cancer: an evidence update for the US Preventive Services Task Force. Agency for Research Health and Quality, Rockville, MD, 2011."},{"key":"2024102403240632000_25.142.472.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60993-8"},{"key":"2024102403240632000_25.142.472.38","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.136978"},{"key":"2024102403240632000_25.142.472.39","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000000258"},{"key":"2024102403240632000_25.142.472.40","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.172.4.10587144"},{"key":"2024102403240632000_25.142.472.41","doi-asserted-by":"publisher","DOI":"10.1378\/chest.108.4.1122"},{"key":"2024102403240632000_25.142.472.42","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/028418518602700507","article-title":"Computed tomography of pleural lesions with special reference to the mediastinal pleura","volume":"27","author":"Salonen","year":"1986","journal-title":"Acta Radiologica Diagnosis (Sweden)"},{"key":"2024102403240632000_25.142.472.43","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.137026"},{"key":"2024102403240632000_25.142.472.44","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2008.100545"},{"key":"2024102403240632000_25.142.472.45","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1378\/chest.118.3.604","article-title":"MRI and CT in the differential diagnosis of pleural disease","volume":"118","author":"Hierholzer","year":"2000","journal-title":"Chest J"},{"key":"2024102403240632000_25.142.472.46","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.16840"},{"key":"2024102403240632000_25.142.472.47","doi-asserted-by":"publisher","DOI":"10.1016\/S0720-048X(01)00426-0"},{"key":"2024102403240632000_25.142.472.48","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ejrad.2008.02.004","article-title":"Malignant pleural mesothelioma: computed tomography and correlation with histology","volume":"70","author":"Seely","year":"2009","journal-title":"Eur J Radiol"},{"key":"2024102403240632000_25.142.472.49","doi-asserted-by":"publisher","DOI":"10.1159\/000056290"},{"key":"2024102403240632000_25.142.472.50","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31826915f1"},{"key":"2024102403240632000_25.142.472.51","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1378\/chest.114.3.713","article-title":"Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography","volume":"114","author":"Benard","year":"1998","journal-title":"Chest J"},{"key":"2024102403240632000_25.142.472.52","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181c0a7ff"},{"key":"2024102403240632000_25.142.472.53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.acra.2013.09.015","article-title":"Diagnostic accuracy of 18F-FDG-PET and PET\/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis","volume":"21","author":"Treglia","year":"2014","journal-title":"Acad Radiol"},{"key":"2024102403240632000_25.142.472.54","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-0820"},{"key":"2024102403240632000_25.142.472.55","doi-asserted-by":"publisher","DOI":"10.1097\/RLI.0b013e3181817b3d"},{"key":"2024102403240632000_25.142.472.56","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(03)00207-1"},{"key":"2024102403240632000_25.142.472.57","doi-asserted-by":"publisher","DOI":"10.1016\/S1010-7940(03)00609-2"},{"key":"2024102403240632000_25.142.472.58","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.12110872"},{"key":"2024102403240632000_25.142.472.59","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1148\/radiol.14132111","article-title":"Malignant pleural mesothelioma: visual assessment by using pleural pointillism at diffusion-weighted MR imaging","volume":"274","author":"Coolen","year":"2014","journal-title":"Radiology"},{"key":"2024102403240632000_25.142.472.60","first-page":"181","article-title":"Characterization of the antigen (CAK1) recognized by monoclonal antibody K1 present on ovarian cancers and normal mesothelium","volume":"52","author":"Chang","year":"1992","journal-title":"Cancer Res"},{"key":"2024102403240632000_25.142.472.61","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0169-5002(93)90527-5","article-title":"Monoclonal antibody K1 reacts with epithelial mesothelioma but not with lung adenocarcinoma","volume":"8","author":"Chang","year":"1993","journal-title":"Lung Cancer"},{"key":"2024102403240632000_25.142.472.62","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318180477b"},{"key":"2024102403240632000_25.142.472.63","doi-asserted-by":"crossref","unstructured":"Creaney J , Robinson BW . Detection of malignant mesothelioma in asbestos-exposed individuals: the potential role of soluble mesothelin-related protein. Hematol Oncol Clin North Am 19: 1025\u20131040.","DOI":"10.1016\/j.hoc.2005.09.007"},{"key":"2024102403240632000_25.142.472.64","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.6671"},{"key":"2024102403240632000_25.142.472.65","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004145"},{"key":"2024102403240632000_25.142.472.66","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-205205"},{"key":"2024102403240632000_25.142.472.67","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1115050"},{"key":"2024102403240632000_25.142.472.68","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200907-1020OC"},{"key":"2024102403240632000_25.142.472.69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046091"},{"key":"2024102403240632000_25.142.472.70","unstructured":"Department of Health. Mesothelioma Service Framework. Dept of Health Lung Cancer and Mesothelioma Advisory Group, London, 2007."},{"key":"2024102403240632000_25.142.472.71","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012092"},{"key":"2024102403240632000_25.142.472.72","doi-asserted-by":"crossref","first-page":"384","DOI":"10.12968\/hmed.2015.76.7.384","article-title":"Medical and oncological management of malignant mesothelioma","volume":"76","author":"Bibby","year":"2015","journal-title":"Br J Hosp Med (Lond)"},{"key":"2024102403240632000_25.142.472.73","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc1039"},{"key":"2024102403240632000_25.142.472.74","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.11.136"},{"key":"2024102403240632000_25.142.472.75","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20005.14.589"},{"key":"2024102403240632000_25.142.472.76","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-5002(02)00180-0"},{"key":"2024102403240632000_25.142.472.77","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.3190"},{"key":"2024102403240632000_25.142.472.78","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604442"},{"key":"2024102403240632000_25.142.472.79","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm501"},{"key":"2024102403240632000_25.142.472.80","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31817c73d6"},{"key":"2024102403240632000_25.142.472.81","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.5.1335"},{"key":"2024102403240632000_25.142.472.82","doi-asserted-by":"publisher","DOI":"10.1097\/01243894-200601000-00007"},{"key":"2024102403240632000_25.142.472.83","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.lungcan.2008.04.001","article-title":"The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma","volume":"63","author":"Stebbing","year":"2009","journal-title":"Lung Canc"},{"key":"2024102403240632000_25.142.472.84","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600505"},{"key":"2024102403240632000_25.142.472.85","doi-asserted-by":"publisher","DOI":"10.1097\/01.coc.0000144852.75613.56"},{"key":"2024102403240632000_25.142.472.86","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.9887"},{"key":"2024102403240632000_25.142.472.87","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2010.12.004"},{"key":"2024102403240632000_25.142.472.88","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690650"},{"key":"2024102403240632000_25.142.472.89","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01238-6"},{"key":"2024102403240632000_25.142.472.90","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(15)01311-2","article-title":"A new standard for malignant pleural mesothelioma","volume":"387","author":"Zauderer","year":"2016","journal-title":"Lancet"},{"key":"2024102403240632000_25.142.472.91","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.2675"},{"key":"2024102403240632000_25.142.472.92","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000499"},{"key":"2024102403240632000_25.142.472.93","doi-asserted-by":"publisher","DOI":"10.1378\/chest.108.3.754"},{"key":"2024102403240632000_25.142.472.94","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601957"},{"key":"2024102403240632000_25.142.472.95","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2007.05.022"},{"key":"2024102403240632000_25.142.472.96","doi-asserted-by":"crossref","unstructured":"Treasure T , Sedrakyan A . Pleural mesothelioma: little evidence, still time to do trials. Lancet 364: 1183\u20131185.","DOI":"10.1016\/S0140-6736(04)17108-0"},{"key":"2024102403240632000_25.142.472.97","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30095-X"},{"key":"2024102403240632000_25.142.472.98","doi-asserted-by":"publisher","DOI":"10.1136\/thx.31.1.15"},{"key":"2024102403240632000_25.142.472.99","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199609000-00005"},{"key":"2024102403240632000_25.142.472.100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2004.02.021"},{"key":"2024102403240632000_25.142.472.101","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2006.01.015"},{"key":"2024102403240632000_25.142.472.102","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2004.11.003"},{"key":"2024102403240632000_25.142.472.103","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70149-8"},{"key":"2024102403240632000_25.142.472.104","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jtcvs.2015.10.036","article-title":"Pleurectomy decortication for mesothelioma: the procedure of choice when possible","volume":"151","author":"Flores","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024102403240632000_25.142.472.105","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jtcvs.2015.09.121","article-title":"Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy","volume":"151","author":"Batirel","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024102403240632000_25.142.472.106","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jtcvs.2015.10.054","article-title":"The mesothelioma surgery shift","volume":"151","author":"Flores","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024102403240632000_25.142.472.107","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2007.10.054"},{"key":"2024102403240632000_25.142.472.108","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2013.11.026"},{"key":"2024102403240632000_25.142.472.109","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31824ab6c5"},{"key":"2024102403240632000_25.142.472.110","first-page":"1156","article-title":"A phase II trial of pleurectomy\/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma","volume":"12","author":"Rusch","year":"1994","journal-title":"\u00a0J Clin Oncol"},{"key":"2024102403240632000_25.142.472.111","doi-asserted-by":"publisher","DOI":"10.1007\/BF02303746"},{"key":"2024102403240632000_25.142.472.112","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.6813"},{"key":"2024102403240632000_25.142.472.113","doi-asserted-by":"publisher","DOI":"10.1067\/mtc.2001.116560"},{"key":"2024102403240632000_25.142.472.114","unstructured":"Lim E . MARS 2: A Feasibility Study Comparing (Extended) Pleurectomy Decortication Versus no Pleurectomy Decortication in Patients With Malignant Pleural Mesothelioma (MARS2). NCT02040272. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02040272 Date last updated: April 12 2016. Date last accessed: October 28 2016."},{"key":"2024102403240632000_25.142.472.115","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2007.09.039"},{"key":"2024102403240632000_25.142.472.116","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2004.08.014"},{"key":"2024102403240632000_25.142.472.117","doi-asserted-by":"crossref","unstructured":"Rintoul RC , Ritchie AJ , Edwards JG , et al. Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial. Lancet 384: 1118\u20131127.","DOI":"10.1016\/S0140-6736(14)60418-9"},{"key":"2024102403240632000_25.142.472.118","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.3943"},{"key":"2024102403240632000_25.142.472.119","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00039510"},{"key":"2024102403240632000_25.142.472.120","first-page":"428","article-title":"Systematic review of trimodality therapy for patients with malignant pleural mesothelioma","volume":"1","author":"Cao","year":"2012","journal-title":"Ann Cardiothorac Surg"},{"key":"2024102403240632000_25.142.472.121","doi-asserted-by":"crossref","unstructured":"Stahel RA , Riesterer O , Xyrafas A , et al. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17\/04): a randomised, international, multicentre phase 2 trial. Lancet Oncol 16: 1651\u20131658.","DOI":"10.1016\/S1470-2045(15)00208-9"},{"key":"2024102403240632000_25.142.472.122","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000078"},{"key":"2024102403240632000_25.142.472.123","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jtcvs.2015.09.129","article-title":"Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"151","author":"de Perrot","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024102403240632000_25.142.472.124","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.5535"},{"key":"2024102403240632000_25.142.472.125","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-120-1-199401010-00010"},{"key":"2024102403240632000_25.142.472.126","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1843.2000.00235.x"},{"key":"2024102403240632000_25.142.472.127","doi-asserted-by":"publisher","DOI":"10.1177\/106002809302700627"},{"key":"2024102403240632000_25.142.472.128","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1753465815570307","article-title":"Efficacy and safety profile of autologous blood versus tetracycline pleurodesis for malignant pleural effusion","volume":"9","author":"Keeratichananont","year":"2015","journal-title":"Therap Adv Respir Dis"},{"key":"2024102403240632000_25.142.472.129","first-page":"964","article-title":"Interventions for the management of malignant pleural effusions: a network meta-analysis","volume":"71","author":"Clive","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2024102403240632000_25.142.472.130","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.01.00225601"},{"key":"2024102403240632000_25.142.472.131","doi-asserted-by":"publisher","DOI":"10.1378\/chest.106.2.342"},{"key":"2024102403240632000_25.142.472.132","first-page":"131S","article-title":"Talc pleurodesis. Prospective and randomized study. Clinical follow-up","volume":"118","author":"Manes","year":"2000","journal-title":"Chest"},{"key":"2024102403240632000_25.142.472.133","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.3.909"},{"key":"2024102403240632000_25.142.472.134","doi-asserted-by":"crossref","first-page":"A15","DOI":"10.1136\/thoraxjnl-2015-207770.25","article-title":"S19 interventions for the management of malignant pleural effusions","volume":"70","author":"Clive","year":"2015","journal-title":"Thorax"},{"key":"2024102403240632000_25.142.472.135","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2012.5543","article-title":"Treatment options for malignant pleural effusions: patient preference does matter","volume":"307","author":"Maskell","year":"2012","journal-title":"JAMA"},{"key":"2024102403240632000_25.142.472.136","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/1745-6215-15-367","article-title":"A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study protocol for a randomised controlled trial","volume":"15","author":"Gunatilake","year":"2014","journal-title":"Trials"},{"key":"2024102403240632000_25.142.472.137","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.7634"},{"key":"2024102403240632000_25.142.472.138","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1940"},{"key":"2024102403240632000_25.142.472.139","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2005.04.010"},{"key":"2024102403240632000_25.142.472.140","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31825f22ee"},{"key":"2024102403240632000_25.142.472.141","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70381-4"},{"key":"2024102403240632000_25.142.472.142","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00092-2"},{"key":"2024102403240632000_25.142.472.143","doi-asserted-by":"crossref","first-page":"CT103","DOI":"10.1158\/1538-7445.AM2015-CT103","article-title":"Clinical safety and efficacy of pembrolizumab (MK-3475) in patients with malignant pleural mesothelioma: preliminary results from KEYNOTE-028","volume":"75","author":"Alley","year":"2015","journal-title":"Cancer Res"},{"key":"2024102403240632000_25.142.472.144","first-page":"S630","volume":"10","author":"Kindler","year":"2015","journal-title":"J Thorac Oncol"},{"key":"2024102403240632000_25.142.472.145","doi-asserted-by":"crossref","first-page":"TPS7609","DOI":"10.1200\/jco.2014.32.15_suppl.tps7609","volume":"32","author":"Cornelissen","year":"2014","journal-title":"J Clin Oncol"},{"key":"2024102403240632000_25.142.472.146","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-15-0064"},{"key":"2024102403240632000_25.142.472.147","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv514.06"},{"key":"2024102403240632000_25.142.472.148","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504030"},{"key":"2024102403240632000_25.142.472.149","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2009.07.016"},{"key":"2024102403240632000_25.142.472.150","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0804"},{"key":"2024102403240632000_25.142.472.151","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28875"},{"key":"2024102403240632000_25.142.472.152","doi-asserted-by":"crossref","first-page":"7565","DOI":"10.1200\/jco.2015.33.15_suppl.7565","volume":"33","author":"Hassan","year":"2015","journal-title":"J Clin Oncol"},{"key":"2024102403240632000_25.142.472.153","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0170"},{"key":"2024102403240632000_25.142.472.154","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2133"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0063-2016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T23:59:05Z","timestamp":1740355145000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0063-2016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,30]]},"references-count":154,"journal-issue":{"issue":"142","published-online":{"date-parts":[[2016,11,30]]},"published-print":{"date-parts":[[2016,12]]}},"alternative-id":["10.1183\/16000617.0063-2016"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0063-2016","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,30]]}}}